Moderna, Inc. (MRNA) Q1 2022 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President and Head of Investor Relations Stephane Bancel — Chief…
Moderna Inc. (MRNA) Q1 2022 Earnings Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President and Head of Investor Relations Stephane Bancel — Chief…
Moderna, Inc. (MRNA) Q4 2021 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q4 2021 earnings call dated Feb. 24, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President & Head of Investor Relations Stephane Bancel — Chief Executive…
Analysis
Moderna (MRNA): Here are a few points to note while considering this stock
Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% on Monday. The stock has gained 291% since the beginning of the year and 149% over…
Moderna, Inc. (MRNA) Q2 2021 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q2 2021 earnings call dated Aug. 05, 2021 Corporate Participants: Lavina Talukdar — Senior Vice President & Head of Investor Relations Stephane Bancel — Chief…
Market News
Moderna, Inc. (MRNA) Q1 2021 Earnings Call
Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Lavina Talukdar — Senior Vice President and Head of Investor Relations Stephane Bancel — Chief Executive…
Moderna, Inc. (MRNA) Q1 2021 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Lavina Talukdar — Senior Vice President and Head of Investor Relations Stephane Bancel — Chief…
Market News
Moderna (MRNA): COVID-19 vaccine helps company deliver first ever profitable quarter
Shares of Moderna Inc. (NASDAQ: MRNA) were down 3% in morning hours on Thursday despite the company reporting the first profitable quarter in its history.…
Market News
Moderna (MRNA) to increase vaccine supply capacity and accelerate pipeline investments
Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% in morning trade on Thursday after the company reported its fourth quarter and full year 2020…
Market News
Moderna (MRNA): Development programs, additional approvals provide optimism
Moderna Inc. (NASDAQ: MRNA) seems to be on a roll right now. The stock has skyrocketed over 500% in the past one year and has…